Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014

Pharmaceutical Microbiology

21 Jan 2014 - 22 Jan 2014 - London, UK

Bookmark and Share

SMi’s reputable Pharamceutical Microbiology conference returns for its 3rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.


Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.


Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

Mary-Anne Weatherhead, Qualified Person, Pfizer

Andrew Bartko, Senior Scientist, Battelle

William Wade, Professor of Oral Microbiology, Barts and The London

Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

Amy McDaniel, Associate Director, Production Operations, Pfizer

Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

Stephen Rawling, Microbiology Team Leader, GSK

John Duguid, Principal Process Analytical Scientist, Genzyme

Kim Bowers, Senior Supervisor, Pfizer

Hilary Chan, Quality Scientist IV, Pfizer

Erika Pfeiler, Microbiologist, FDA

Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Be sure to take part in the next instalment by registering online at:

Alternatively contact John Collins on +44(0)20 7827 6734 or email

Further information
Scientific News
Inroads Against Leukemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Nanoparticles Can Make Medicines More Effective
Nanoparticles wrapped inside human platelet membranes serve as new vehicles for targeted drug delivery.
A Better Class of Cancer Drugs
An SDSU chemist has developed a technique to identify potential cancer drugs that are less likely to produce side effects.
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos